-
Biomarkers in Human Cerebrospinal Fluid
… proteomic technique (iTRAQ) that can quantitatively compare multiple disease settings simultaneously. The goal of this …
-
Specific Modulation of Tau Oligomers by Passive Immunotherapy in a Parkinson's Disease Model
… its effects on the PD-like phenotypes will be assessed by multiple approaches. In the prevention study, young models … After the final behavioral evaluation, models will be systematically analyzed. Relevance to Diagnosis/Treatment of …
-
A Pair of Neurotrophic Factor Inducing Drug Candidates
… There are no drugs that induce multiple growth factors, independently activate neurotrophin …
-
Saliva Alpha-synuclein Levels in LRRK2 Mutation Carriers
… need to be replicated in a study with samples collected at multiple time points, including before the appearance of PD …
-
Michael J. Fox Foundation Awards $2.9 Million for Two New Parkinson's Disease Clinical Trials
April 2, 2009
… at www.michaeljfox.org . A Randomized, Placebo-controlled, Multiple Crossover (n-of-1), Pilot trial of Simvastatin on …
-
Phase II Trial of Bone Marrow-Derived Mesenchymal Stem Cells as a Disease-Modifying Therapy for Parkinson’s Disease
… on the safety, effectiveness, and mechanism of action of multiple infusions of mesenchymal stem cells as a …